NCT00176306View on ClinicalTrials.gov

Levofloxacin Pharmacokinetics (PK) in the Severely Obese

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
ObesityCritical Illness
Interventions
DRUG

Levofloxacin 750 mg IV

PK in obesity

Trial Locations (1)

40536

University of Kentucky, Lexington

Sponsors
All Listed Sponsors
collaborator

Ortho-McNeil Pharmaceutical

INDUSTRY

lead

Joel Thompson, PhD

OTHER